Cargando…
COVID-19 hits a trial: Arguments against hastily deviating from the plan
The COVID-19 pandemic has substantially impacted the conduct of clinical trials. While initially preparing for a period of time, where it would likely be impossible to supervise trials in the usual way and precautionary measures had to be implemented to care for medication supply and general safety...
Autores principales: | Großhennig, Anika, Koch, Armin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831554/ https://www.ncbi.nlm.nih.gov/pubmed/32961360 http://dx.doi.org/10.1016/j.cct.2020.106155 |
Ejemplares similares
-
Answering hastily retards learning
por: Yawata, Yosuke, et al.
Publicado: (2018) -
Critical appraisal of arguments for the delayed-start design proposed as alternative to the parallel-group randomized clinical trial design in the field of rare disease
por: Spineli, Loukia M., et al.
Publicado: (2017) -
Fighting SARS with a Hastily Formed Network
por: van Baalen, Peter J., et al.
Publicado: (2009) -
Introduction to the theory and application of differential equations with deviating arguments
por: Elsgolts, L E, et al.
Publicado: (1973) -
Personalized medicine using DNA biomarkers: a review
por: Ziegler, Andreas, et al.
Publicado: (2012)